BlackRock Inc. - ACURX PHARMACEUTICALS INC ownership

ACURX PHARMACEUTICALS INC's ticker is ACXP and the CUSIP is 00510M104. A total of 13 filers reported holding ACURX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ACURX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$27,189
-45.6%
18,126
-4.0%
0.00%
Q2 2023$50,019
-10.5%
18,875
+16.8%
0.00%
Q1 2023$55,917
-10.2%
16,161
+3.3%
0.00%
Q4 2022$62,243
+32.4%
15,639
+0.6%
0.00%
Q3 2022$47,000
-23.0%
15,549
-2.7%
0.00%
Q2 2022$61,000
+10.9%
15,984
-4.3%
0.00%
Q1 2022$55,000
+89.7%
16,699
+149.8%
0.00%
Q4 2021$29,000
-12.1%
6,685
+2.6%
0.00%
Q3 2021$33,0006,5150.00%
Other shareholders
ACURX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Draper Asset Management, LLC 266,025$1,058,7801.47%
ARMISTICE CAPITAL, LLC 880,000$3,502,4000.06%
Semmax Financial Advisors Inc. 5,879$240.01%
Belpointe Asset Management LLC 3,000$11,9400.00%
TD Waterhouse Canada Inc. 18,656$77,4220.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 10,100$40,1980.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 77,283$3070.00%
MILLENNIUM MANAGEMENT LLC 29,096$1160.00%
BlackRock Inc. 15,639$62,2430.00%
View complete list of ACURX PHARMACEUTICALS INC shareholders